Vukovic Vojo 4

What Happened Vojo Vukovic, Chief Medical Officer of Delcath Systems, Inc. (DCTH), received two equity awards on February 17, 2026: a grant of options covering 56,500 shares and a restricted stock unit (RSU) award for 28,250 shares. Both awards are reported at $0 consideration (typical for stock-based compensation grants) and therefore show no cash paid or received.

Key Details

• Transaction date: February 17, 2026; Form 4 filed February 18, 2026.
• Awards: 56,500-share option grant (derivative) and 28,250 RSUs (derivative); both reported at $0.00 per share.
• Vesting for the option (F1): vests 1/36th per month beginning Feb 17, 2026 (monthly over 36 months), subject to continued employment and plan terms.
• Vesting for the RSUs (F2/F3): 1/3 vests on Feb 17, 2027; the remaining 2/3 vest in equal annual installments over the next two years (i.e., annual vesting on subsequent anniversaries), subject to continued service.
• Awards governed by the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan (as amended).
• Amount owned following the transaction is not specified in the provided excerpt.

Context These entries are equity compensation grants (coded "A" for award/grant) rather than open-market purchases or sales, so they reflect company compensation decisions, not immediate insider buying or selling. The option vests monthly over three years; the RSUs convert to common shares only as they vest and subject to continued employment. Because the reported price is $0, there was no cash outlay reported on the Form 4 for these awards.